SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
46 hedge funds and large institutions have $38.6M invested in Sorrento Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
24% more funds holding
Funds holding: 37 → 46 (+9)
Holders
46
Holding in Top 10
2
Calls
$103K
Puts
$25K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$1.14M | |
| 3 | +$845K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$834K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$427K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$977K | |
| 3 | -$397K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$209K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$150K |